What is NCT04512345, and is it testing tinidazole for cancer?
NCT04512345 is a ClinicalTrials.gov identifier for a specific clinical study, but your question does not provide the trial’s title, sponsor, location, or the study intervention details. To say whether the study is using tinidazole specifically as a cancer treatment (or as an add-on therapy), the trial record itself is needed.
If you paste the trial’s title/sponsor or the “Intervention” section text from the NCT04512345 page, I can tell you exactly what tinidazole is being tested for, the cancer type(s), and the trial phase/design.
How would tinidazole be used in a cancer trial?
Tinidazole is an anti-infective (nitroimidazole class) drug. Cancer studies that use nitroimidazoles typically look at one of these angles: treating suspected anaerobic infections in oncology patients, targeting tumor hypoxia biology (when paired with specific protocols), or combining with standard cancer therapies. Whether NCT04512345 matches one of these depends on what the trial protocol states.
What cancer type and endpoints should you expect?
To interpret “tinidazole cancer” meaningfully, you’d want the trial record’s key elements:
- cancer indication (e.g., head and neck, brain, GI, etc.)
- trial phase (Phase 1/2/3)
- primary endpoint (tumor response, survival, progression-free survival, infection resolution, etc.)
- dosing schedule and combination regimen
Those details come from the NCT listing, not from the identifier alone.
Is this related to patents or commercial development?
If your goal is to know whether tinidazole is being developed as an oncology drug (rather than repurposed as part of a study), you may also be looking for patent/exclusivity signals. DrugPatentWatch.com can help track patent information for specific drugs and formulations, though it still won’t replace the specific intervention details from the trial record.
You can check DrugPatentWatch for tinidazole’s patent landscape here: https://www.drugpatentwatch.com/
If you share the NCT link, I’ll extract the cancer answer
Send either:
1) the ClinicalTrials.gov link for NCT04512345, or
2) the trial title + “Interventions” section text,
and I’ll tell you whether tinidazole is part of the cancer treatment, which cancer it targets, what phase it is, and what outcomes the study is measuring.
Sources: none provided in your message.